UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055780
Receipt number R000063749
Scientific Title A study on the effects and comfort of a non-symmetrical high-flow nasal oxygen cannula
Date of disclosure of the study information 2024/10/21
Last modified on 2024/10/08 14:45:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the effects and comfort of a non-symmetrical high-flow nasal oxygen cannula

Acronym

A study on the effects and comfort of a non-symmetrical high-flow nasal oxygen cannula

Scientific Title

A study on the effects and comfort of a non-symmetrical high-flow nasal oxygen cannula

Scientific Title:Acronym

A study on the effects and comfort of a non-symmetrical high-flow nasal oxygen cannula

Region

Japan


Condition

Condition

respiratory failure, heart failure

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study will investigate whether a asymmetrical high-flow nasal cannula device provides improved carbon dioxide clearance and comfort compared to a conventional HFNC device.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The difference in ventilation volume between devices will be used as the evaluation item.
The patient wears electrodes for electrical impedance tomography (EIT) so that the ventilation volume under spontaneous breathing can be estimated from the measured electrical resistance.
The patient wears each device and sets the flow rate provided by each device. After breathing naturally for 15 minutes, the ventilation volume is estimated using the electrical resistance recorded by EIT.
The estimated ventilation volume is compared between each device

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

To compare the asymmetrical HFNC with the conventional HFNC, the devices will be fitted to the patient in turn(asymmetric -> conventional), and the effect of each will be verified by changing the flow rate provided. The order of fitting the asymmetrical device and the conventional device will be randomised.

Interventions/Control_2

To compare the asymmetrical HFNC with the conventional HFNC, the devices will be fitted to the patient in turn(conventional -> asymmetric), and the effect of each will be verified by changing the flow rate provided. The order of fitting the asymmetrical device and the conventional device will be randomised.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients aged 18 and over who require treatment with HFNC at ICU.
Patients who are legally competent to give consent.

Key exclusion criteria

1) Patients with significant respiratory instability or respiratory acidosis, for whom the insertion and removal of the device is deemed to be dangerous
2) Pregnant patients
3) Patients with neuromuscular disorders
4) Patients who have difficulty following the breathing instructions given to them
5) Patients with extremely sensitive skin
6) Patients with nasogastric tubes in place
7) Patients deemed to be unsuitable for the procedure by the doctor

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Tobe

Organization

Gunma university hospital

Division name

Intensive care unit

Zip code

371-8511

Address

3-39-15 Showa-machi, Mebashi-shi, Gunma prefecture

TEL

027-220-8698

Email

tbc0211@yahoo.co.jp


Public contact

Name of contact person

1st name Kensuke
Middle name
Last name Sugimoto

Organization

Gunma university hospital

Division name

Intensive care unit

Zip code

371-8511

Address

3-39-15 Showa-machi, Mebashi-shi, Gunma prefecture

TEL

027-220-8698

Homepage URL


Email

k.sugimoto1003@gmail.com


Sponsor or person

Institute

Gunma university

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University Hospital Clinical Research Review Board

Address

3-39-15 Showa-machi, Mebashi-shi, Gunma prefecture

Tel

027-220-8740

Email

irb-jimukk-ciru@ml.gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 06 Month 17 Day

Date of IRB


Anticipated trial start date

2024 Year 10 Month 21 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 08 Day

Last modified on

2024 Year 10 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063749